Advisory Services Network’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Advisory Services Network’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,600	Closed	-$12K	–	3127
2020 Q4	$12K	Sell	3,600 -5,100	-59%	-$19.4K	﹤0.01%	2364
2020 Q3	$29K	Buy	+8,700	New	+$32K	﹤0.01%	1890
2020 Q2	–	Sell	-7,000	Closed	-$27K	–	2903
2020 Q1	$27K	Buy	+7,000	New	+$32.5K	﹤0.01%	1707
2018 Q4	–	Sell	-300	Closed	-$2K	–	2707
2018 Q3	$2K	Buy	+300	New	+$2.3K	﹤0.01%	2341

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Advisory Services Network's ZYNE Position: Q1 2021 in Review

Advisory Services Network sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2021, closing a stake of 3,600 shares — an estimated $12K sold.

Advisory Services Network first reported a position in ZYNE in Q3 2018 and held it in 4 quarters. The position peaked at $29K in Q3 2020. 67 funds tracked by Wall St. Rank hold ZYNE as of Q1 2021.

Advisory Services Network reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2021 after selling out during the quarter.
Advisory Services Network sold 3,600 Zynerba Pharmaceuticals, Inc shares in Q1 2021, an estimated $12K.
Advisory Services Network first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2018 and held it in 4 quarters.
Advisory Services Network's Zynerba Pharmaceuticals, Inc position peaked at $29K in Q3 2020.
67 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.